False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 888-890

  Weinblatt, Mark E ^a,b   Zanzi, Italo ^a   Belakhlef, Abdelfathie ^a   Babchyck, Barry ^a   Kochen, Joseph ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

FDG PET; Hodgkin's disease; Pediatrics; Thymus

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYMUS; TUMOR LOCALIZATION;

CHILD; DEOXYGLUCOSE; FALSE POSITIVE REACTIONS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; THYMUS NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030965845     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Israel O, Front D, Epelbaum R, et al. Residual mass and negative gallium scintigraphy in treated lymphoma. J Nucl Med 1990;31:365-368.
2. 67Ga citrate imaging for detection of lymphoma. J Nucl Med 1987;28:288-292.
3. 18F-FDG in malignant lymphoma: a comparison with proliferative actitivity. J Nucl Med 1992;33:325-329.
4. Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body PET and FDG. Cancer 1993;72:82-90.
5. Zanzi I, Vinciguerra V, Schulman P, et al. Evaluation of malignant lymphoma with FDG/PET studies [Abstract], Eur J Nucl Med 1993;20:977.
6. 18F-2-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994;190:111-116.
7. 18F-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995;194:495-500.
8. 18F-FDG using a synthetic unit made of sterile disposable components and operated by a master slave manipulator. Appl Radiat Isot 1990;41:29-34.
9. Wahl RL, Zassadry K, Helvie M, et al. Metabolic monitoring using chemohormonotherapy using PET initial evaluation. J Clin Oncol 1993;11:2101-2111.
10. Zanzi I, Robeson W, Vinciguerra V, et al. Imaging of gastrointestinal neoplasms with PET [Abstract], Eur J Nucl Med 1991;18:687.
11. Jochelson M, Mauch P, Balikian J, et al. The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol 1985;3:637-640.
12. Luker GD, Siegel MJ. Mediastinal Hodgkin's disease in children: response to therapy. Radiology 1993;189:737-740.
13. Anderson KC, Leonard RCF, Canellos GP, et al. High-dose gallium imaging in lymphoma. Am J Med 1983;75:327-331.
14. Gasparini MD, Balzarini L, Castellani MR, et al. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma. Cancer 1993;72:577-582.
15. Even-Sapir E, Bar-Shalom R, Israel O, et al. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 1995;13:942-946.
16. Cohen M, Hill CA,Cangir A, Sullivan MP. Thymic rebound after treatment of childhood tumors. Am J Radiology 1980;135:151-156.
17. 67Ga after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. J Clin Oncol 1989;7:1800-1806.
18. Chapman PE, Groshar D, Hooper HR, et al. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma? Nurl Med Commun 1992;13:730-737.
19. 67Ga scanning. Radiology 1993;187:381-386.
20. 18F-FDG and PET. Neurol 1982;32:1323-1329.
21. Patz EF, Goodman PC. PET imaging of the thorax. Adv Chest Radiology 1994;32: 811-823.
22. Bares R, Galonska P, Dempke W, et al. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by PET. Horm Metab Res Suppl 1993;27:56-58.
23. Rettonbacher, Galvan G. Differentiation between residual cancer and thymic hyper-plasia in malignant non-Hodgkin's lymphoma with somatostatin receptor scintigraphy. Clin Nucl Med 1994;19:64-65.
24. Harris EW, Rakow JI, Weiner M, Agress H. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease. J Nucl Med 1993;34:1326-1330.